JOINT &
MOBILITY JOURNAL

THE EVIDENCE FOR
MOVING WELL.

Joint Support / EXPLAINED

PRP for knee osteoarthritis: placebo-controlled trials still disagree

Large and newer placebo-controlled PRP trials report different symptom and MRI results. Preparation methods and primary outcomes explain why certainty remains limited.

Microscopy image showing blood platelets
Platelet-rich plasma is prepared from a person’s blood, but platelet concentration and final composition vary among protocols. Image credit
THE USEFUL TAKEAWAY

PRP remains difficult to judge because placebo-controlled trials use different preparations and report conflicting symptom and structural findings.

Your own blood can still produce a variable treatment

Platelet-rich plasma sounds standardized because it starts with a patient’s blood. In practice, centrifugation, platelet concentration, white-cell content, activation, injection number and timing can all differ. That variability helps explain why one PRP headline may not predict another clinic’s result.

The problem resembles the negative bromelain placebo trial: a result from one defined preparation cannot validate every treatment carrying the same category name. For PRP, the clinic protocol is part of the intervention.

The RESTORE trial found no meaningful advantage

The 2021 RESTORE trial randomized 288 adults with mild-to-moderate medial knee osteoarthritis to three weekly PRP or saline injections. At 12 months, PRP did not produce a significant improvement in pain or medial tibial cartilage volume compared with placebo.

This was a large, blinded, placebo-controlled study with symptom and structural outcomes. It weighs heavily against broad promises that PRP reliably relieves pain or preserves cartilage. It does not prove that every protocol is ineffective, but it raises the standard for positive claims.

Medical laboratory centrifuge used to separate blood components
Centrifugation is central to PRP preparation; single- and double-spin methods can produce different products. Image credit

A 2025 MRI trial reported a more favorable pattern

A newer randomized double-blind trial compared single-spin PRP, double-spin PRP and saline over six months. The authors reported favorable differences for several pain, function and MRI measures in the PRP groups, while osteophytes and subchondral cyst findings did not clearly differ.

The result deserves attention, but one smaller study does not erase RESTORE. Different protocols, populations, analysis plans and follow-up can change the answer. The MSM knee-osteoarthritis guide likewise keeps a promising signal separate from a settled treatment conclusion.

Ask the clinic for the protocol, not a slogan

Before paying, ask how many injections are recommended, whether the product is leukocyte-rich or leukocyte-poor, how platelets are measured, what evidence supports that protocol, and what total cost includes. Request the clinician’s expected timeline and a plan if symptoms do not improve.

Also ask about infection precautions, anticoagulants, anemia, blood disorders and post-procedure activity. PRP is a medical procedure, not a food supplement. Eligibility and risk depend on the person and the practice, and insurance coverage can vary.

Polarized-light microscopy image of cartilage tissue
Cartilage has an organized microscopic structure; MRI or symptom findings should not be translated into a claim of complete cartilage regrowth. Image credit

Pain relief and cartilage change must remain separate

A person may value pain relief even if imaging does not change. Conversely, an MRI measurement can shift without producing a noticeable improvement in daily life. Trials should state a primary outcome so readers are not invited to choose whichever secondary result sounds best afterward.

The pine-bark knee evidence also shows why symptom findings cannot by themselves prove cartilage rebuilding. Words such as regenerative or healing should not replace direct, durable structural evidence tied to better patient outcomes.

Make the decision with uncertainty visible

PRP may remain reasonable to discuss after diagnosis, exercise therapy and established options have been reviewed, especially when a clinician explains the protocol and uncertainty clearly. It should not be sold as a guaranteed way to avoid surgery or regrow a normal joint surface.

Define success before the first injection, use a repeatable pain and function measure, and set a review date. The current research contains both negative and favorable placebo-controlled results. Conflicting trials are not a reason for panic or hype; they are a reason to demand precise information before accepting a costly procedure. The guide to reading a joint supplement trial explains why planned comparisons and outcomes shape the conclusion.

Cost and follow-up deserve the same scrutiny

PRP is often paid for out of pocket, and clinics may recommend different numbers of injections. Request the full price, follow-up schedule and cancellation terms in writing. Ask whether additional imaging, braces or rehabilitation are separate costs and whether unused visits are refundable.

A high price is not evidence of a stronger preparation. Compare the clinic’s claims with the exact placebo-controlled protocol it cites. If the marketing promises guaranteed regeneration, a permanent result or a precise success rate without a matching source, that is a reason to slow down.

Keep copies of consent forms, preparation details and procedure notes. If another clinician later reviews the knee, those records show what was injected, when it was given and how the joint responded.

Sources & further reading
  1. Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection: RESTORE Randomized Clinical Trial ↗
  2. MRI Findings after Single- and Double-Centrifuged PRP and Placebo in Knee Osteoarthritis ↗
  3. PIKOA placebo-controlled PRP trial protocol ↗